The Filing Desk

AdvanSix

ASIX · NYSE · Materials · Financials, fiscal 2016 to 2025

ASIX · Last close · November 13, 2026
$15.68
Value AdvanSix yourself

AdvanSix's revenue rose 0.3% to $1.5 billion in fiscal 2025. Its net margin was 3.2%, up from 2.9% a year earlier. Free cash flow was $6 million, up 279.5%. It paid out $19 million in dividends and buybacks, 293% of free cash flow. The diluted share count rose 0.3%.

AdvanSix Inc. Latest fiscal year ended December 31, 2025 10-K filed February 20, 2026 · 0001673985-26-000008 Updated
Revenue
$1.5B
0.3%
Net margin
3.2%
0.3 pts
Net income
$49M
11.6%
Free cash flow
$6M
279.5%
Return on capital
7.1%
0.3 pts
Market cap
$425M
Nov 13 close
P/E
—
Loss: no P/E

Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What AdvanSix does

AdvanSix is a U.S. chemical maker that Honeywell spun off in 2016. It runs five manufacturing plants in the United States and sells materials used in building and construction, farming, plastics, packaging, paints, adhesives and electronics.

It has three product groups. Nylon solutions are Nylon 6 resin, which customers turn into fibers, plastics and films for carpets, car parts, sports clothing and food packaging, and caprolactam, the main ingredient of that resin. Plant nutrients are mostly ammonium sulfate, a fertilizer that supplies nitrogen and sulfur, sold mainly to distributors, farm cooperatives and retailers in North and South America. Chemical intermediates are products such as acetone, phenol and cyclohexanone, which go into solvents, paints, coatings, adhesives and herbicides.

Most of this comes from its Hopewell, Virginia plant, where one process feeds the next. The company says the plant is the world's largest single-site producer of ammonium sulfate and one of the largest of caprolactam. At the end of 2025 it employed about 1,410 people.

Its biggest risks, as it describes them

  • Swings in the industries it sells to, which can sharply change its cash flows.
  • Higher costs for raw materials such as cumene, natural gas and sulfur that it cannot pass on to customers.
  • Downtime or accidents at its few production plants, including hazards of making and shipping chemicals.
  • Losing one or more of its significant customers.
  • Needing large amounts of capital for its plants and growth projects, which may not be available on good terms.
From AdvanSix's annual report on Form 10-K, filed February 20, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2025, earnings per share grew 5.4% a year and net income 4.2% a year, as buybacks cut the share count by 10%.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments1531302020
Debt incl. finance leases136117222
Net debt (negative means net cash)12186−28−17−18
Net debt to EBITDA0.5x0.3x−0.2x−0.1x−0.1x
Debt to equity0.2x0.2x0.0x0.0x0.0x
Interest coverage42.5x101.8x10.8x5.2x9.1x
Current ratio1.1x1.1x1.2x1.1x1.1x
Quick ratio0.7x0.6x0.6x0.5x0.5x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project AdvanSix's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What AdvanSix says to expect

  • Full year 2026: capital expendituresNow expect Capital Expenditures of approximately $90 million in 2026 versus $116 million in 2025, reflecting risk-based prioritization of base investments and enterprise programs with continued progression of growth programs including SUSTAIN
  • Full year 2026: plant turnaroundsContinue to expect pre-tax income impact of plant turnarounds to be approximately $17 million in 2026 versus $25 million in 2025
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 4, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

No officer, director or 10% owner of AdvanSix reported buying or selling its shares on the open market between November 14, 2025 and November 13, 2026.

From Form 4 filings with the SEC. Grants, option exercises and shares withheld for tax aren't counted. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score6 of 94 of 96 of 9
Rule of 40−20.5%−0.9%0.7%
Altman Z''2.952.642.66
Accruals ratio−4.2%−5.9%−4.5%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets roseFailFailPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailFail
Current ratio rosePassFailPass
Share count didn't risePassPassFail
Gross margin roseFailFailPass
Revenue rose relative to assetsFailFailFail
F-score6 of 94 of 96 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put AdvanSix side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
AdvanSixFY250.3%—0.4%7.1%−0.1x6
Sensient TechnologiesFY253.5%12.8%2.4%8.9%2.5x6Compare
InnospecFY25−3.6%7.3%5.0%11.1%−1.7x6Compare
Quaker ChemicalFY252.7%2.8%4.3%1.3%6.1x5Compare
IngevityFY25−2.7%35.9%23.4%24.6%2.1x6Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue1,1921,4751,5151,2971,1581,6851,9461,5341,5181,522
Revenue growth−10.4%23.8%2.7%−14.4%−10.8%45.5%15.5%−21.2%−1.1%0.3%
Gross profit108227174136134274314165153165
Research and development141315141214121099
Operating income——————————
Net income34147664146140172554449
Diluted EPS (US$)1.124.722.141.431.644.815.921.951.621.80
Diluted shares (millions)30313129282929282727
Cash flow
Cash from operations114135173120112219274118135123
Capital expenditure8486109150835789107134116
Free cash flow304864−30291621841026
Dividends paid00000415171717
Share buybacks003862113446102
Acquisitions000001098000
Stock-based compensation1810851110887
Balance sheet at fiscal year end
Cash and short-term investments1455107111531302020
Debt incl. finance leases265248200298276136117222
Total assets9051,0501,0351,2361,2631,3121,4951,4961,5951,706
Total liabilities690674614835819711757757820891
Shareholders' equity215376420401444601738739775815
Margins and ratios
Gross margin9.0%15.4%11.5%10.4%11.6%16.3%16.2%10.8%10.1%10.8%
Operating margin——————————
Net margin2.9%9.9%4.4%3.2%4.0%8.3%8.8%3.6%2.9%3.2%
Free cash flow margin2.5%3.3%4.2%−2.3%2.5%9.6%9.5%0.7%0.1%0.4%
Rule of 40 (growth + FCF margin)−7.9%27.1%6.9%−16.7%−8.2%55.1%25.0%−20.5%−0.9%0.7%
Return on capital—29.3%12.0%7.0%7.5%20.0%22.4%7.8%7.4%7.1%
Return on equity9.8%49.6%16.6%10.1%10.9%26.8%25.7%7.4%5.8%6.2%
Return on assets3.9%15.0%6.3%3.6%3.7%10.9%12.2%3.6%2.9%3.0%
Net debt to EBITDA2.6x1.0x1.3x2.5x2.1x0.5x0.3x−0.2x−0.1x−0.1x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: AdvanSix's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with AdvanSix.